VieCure Expands Precision Oncology Ecosystem Through Partnership with Guardant Health
VieCure has partnered with Guardant Health to integrate Guardant’s precision oncology tests into the AI-powered Halo Intelligence platform.
VieCure has partnered with Guardant Health to integrate Guardant’s precision oncology tests into the AI-powered Halo Intelligence platform.
Guardant Health partnered with Epic, a health record company, to integrate the oncology company’s portfolio of cancer tests with its services.
The collaborators are pursuing regulatory approval of the Guardant360 CDx as a companion diagnostic for amivantamab for the treatment of NSCLC.